Shape Therapeutics
Home - ShapeTX
Seattle, United States · Founded 2019 · $147.5M raised
- Headquarters
- Seattle, Washington
- Employees
- 51–200
- Founded
- 2019
- Business Model
- B2B
- Website
- shapetx.com
- Total Funding
- $147.5M
- Last Round
- $112.0M Series B
- Rounds
- 2
About
Shape Therapeutics (ShapeTX) is a preclinical-stage biotechnology company pioneering programmable RNA medicines. Founded 2019 in Seattle. Combines AI with RNA technology to engineer novel RNA therapeutics that correct mutations, fine-tune gene expression, modulate protein interactions. Targets Alzheimer's, Parkinson's, Alpha-1 antitrypsin deficiency.
Summary
Shape Therapeutics is an Artificial Intelligence company based in Seattle, United States, founded in 2019. It has raised $147.5M in total across 2 rounds.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.